For example, Xu et al. reported that inhibiting ITGB2 alleviates inflammatory responses by blocking the recruitment of resting dendritic cells, thereby alleviating inflammatory bowel disease in mice [49]. This evidence concerns the gene ITGB2 and inflammatory bowel disease.